These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 3533488)

  • 1. Antimicrobial surveillance in a VAMC teaching hospital--resulting cost avoidance.
    Powers DA
    Drug Intell Clin Pharm; 1986 Oct; 20(10):803-5. PubMed ID: 3533488
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibiotic surveillance: the results of a clinical pharmacy intervention program.
    Capers CC; Bess DT; Branam AC; Falbe WJ; Mrochek SA; Haymond JD; Stahl AA
    Hosp Pharm; 1993 Mar; 28(3):206-10, 212. PubMed ID: 10124947
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of a two-stage intervention program on cefazolin usage at a major teaching hospital.
    Gupta S; Bachand RL; Jewesson PJ
    Hosp Formul; 1989 Jan; 24(1):41-4, 46. PubMed ID: 10291599
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Savings achieved through cephalosporin surveillance.
    Katz E; Schlamowitz S
    Am J Hosp Pharm; 1978 Dec; 35(12):1521-3. PubMed ID: 717407
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hospital use of antimicrobial drugs. Survey at 19 hospitals and results of antimicrobial control program.
    Craig WA; Uman SJ; Shaw WR; Ramgopal V; Eagan LL; Leopold ET
    Ann Intern Med; 1978 Nov; 89(5 Pt 2 Suppl):793-5. PubMed ID: 717957
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antimicrobial formulary management: a case study in a teaching hospital.
    Wright DB
    Pharmacotherapy; 1991; 11(1 ( Pt 2)):27S-31S. PubMed ID: 2011570
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A strategy to reduce drug expenditures with a drug utilization review program.
    Hoffmann RP
    Hosp Pharm; 1984 Jan; 19(1):7-8, 11-2. PubMed ID: 10264746
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changes in antimicrobial agent usage resulting from interactions among clinical pharmacy, the infectious disease division, and the microbiology laboratory.
    Schentag JJ; Ballow CH; Fritz AL; Paladino JA; Williams JD; Cumbo TJ; Ali RV; Galletta VA; Gutfeld MB; Adelman MH
    Diagn Microbiol Infect Dis; 1993; 16(3):255-64. PubMed ID: 8477582
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Contribution of clinical pharmacists to cefazolin utilization.
    Witte KW; Hatoum HT; Hoon TJ
    Hosp Formul; 1987 Aug; 22(8):737-41. PubMed ID: 10283405
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacy-laboratory interactions: a unique method to control antibiotic costs.
    Goff D; Thornton J
    Hosp Pharm; 1989 Jan; 24(1):26-9, 32. PubMed ID: 10291600
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hospital usage of parenteral antimicrobial agents: a gradated utilization review and cost containment program.
    Pelletier LL
    Infect Control; 1985 Jun; 6(6):226-30. PubMed ID: 3848420
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of antibiotic order form guiding rational use of expensive drugs on cost containment.
    Sirinavin S; Suvanakoot P; Sathapatayavongs B; Malatham K
    Southeast Asian J Trop Med Public Health; 1998 Sep; 29(3):636-42. PubMed ID: 10437971
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Guidelines for peer review. Veterans Administration Ad Hoc Interdisciplinary Advisory Committee on Antimicrobial Drug Usage.
    JAMA; 1977 Mar; 237(10):1001-2. PubMed ID: 319260
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enforcing a policy for restricting antimicrobial drug use.
    Maswoswe JJ; Okpara AU
    Am J Health Syst Pharm; 1995 Jul; 52(13):1433-5. PubMed ID: 7671042
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Surveillance and the costs related to the prescription of antimicrobials in a pediatric hospital].
    Navarrete-Navarro S; Avila-Figueroa C; Medina-Cuevas F; Santos-Preciado JI
    Gac Med Mex; 1999; 135(4):383-9. PubMed ID: 10491893
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Controlling moxalactam and cefotaxime use with a target drug program.
    Abramowitz PW; Ludwig DJ; Mansur JM; Nold EG
    Hosp Pharm; 1983 Aug; 18(8):416-20. PubMed ID: 10261791
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost-effectiveness of prospective and continuous parenteral antibiotic control: experience at the Palo Alto Veterans Affairs Medical Center from 1987 to 1989.
    Coleman RW; Rodondi LC; Kaubisch S; Granzella NB; O'Hanley PD
    Am J Med; 1991 Apr; 90(4):439-44. PubMed ID: 1901446
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antimicrobial expenditures and usage at four university hospitals. Baden-Württemberg Interuniversity Study Group.
    Kern WV; Rose AD; Hay B; Muche R; Frank U
    Infection; 2001; 29(3):127-37. PubMed ID: 11440382
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cost savings achieved through cephalosporin use review and restriction.
    Dzierba SH; Reilly RT; Caselnova DA
    Am J Hosp Pharm; 1986 Sep; 43(9):2194-7. PubMed ID: 3766571
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A targeted review of vancomycin use.
    Piquette RK
    Can J Hosp Pharm; 1991 Apr; 44(2):83-7. PubMed ID: 10111726
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.